Daewoong calls for civil group’s clarification over Ursa dispute
Published: 2013-09-30 06:59:00
Updated: 2013-09-30 06:59:00
Daewoong Pharmaceutical has launched its offensive against the Korean Pharmacists for Democratic Society (KPDS) over the latter’s false efficacy claim that Ursa (ursodeoxycholic acid) is nothing but a digestive agent, far from a drug to combat fatigue.
In a statement on Thursday, the company s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.